Abstract
An increasing number of clinical studies address interactions of cardiovascular drugs in terms of both their importance in the treatment of disease and their potential to cause drug-induced toxicity. Several books and reviews are devoted to extensive listings of both observed and theoretical drug interactions [1–4]. Such listings often include extrapolation of animal data, anecdotal case reports, and interactions of questionable importance. Consequently, their literal use could result in withholding therapy or overcomplicating therapeutic decisions. Some drug interactions are critical for optimum patient care, such as combined use of drugs for their additive or synergistic effects, while others, although academically interesting, have little clinical relevance. In this review, it is not our intent to provide extensive listings of cardiovascular drug interactions but to use clinical examples to illustrate pharmacological principles which may then be extrapolated to individual patients [5].KeywordsDrug InteractionActivate CharcoalFree DrugHepatic Blood FlowCardiovascular DrugThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
